Hagiwara, M., Kikuchi, E., Tanaka, N., Kosaka, T., Mikami, S., Saya, H., & Oya, M. (2018). Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer. BMC Cancer.

Hagiwara, Masayuki, Eiji Kikuchi, Nobuyuki Tanaka, Takeo Kosaka, Shuji Mikami, Hideyuki Saya, i Mototsugu Oya. "Variant Isoforms of CD44 Involves Acquisition of Chemoresistance to Cisplatin and Has Potential As a Novel Indicator for Identifying a Cisplatin-resistant Population in Urothelial Cancer." BMC Cancer 2018.

Hagiwara, Masayuki, et al. "Variant Isoforms of CD44 Involves Acquisition of Chemoresistance to Cisplatin and Has Potential As a Novel Indicator for Identifying a Cisplatin-resistant Population in Urothelial Cancer." BMC Cancer 2018.